- Home
- SANG vs RGC Comparison
SANG vs RGC Comparison
Compare SANG & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SANG | RGC |
|---|---|---|
| Founded | 1984 | 2014 |
| Country | Canada | Hong Kong |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 170.0M | 9.8B |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SANG | RGC |
|---|---|---|
| Price | $5.02 | $20.92 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 3.7K | ★ 328.1K |
| Earning Date | 02-04-2026 | 10-24-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $227,360,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.59 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.08 | $0.09 |
| 52 Week High | $7.99 | $83.60 |
Technical Indicators
Market Signals| Indicator | SANG | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 46.23 | 57.60 |
| Support Level | $4.86 | $19.80 |
| Resistance Level | $5.08 | $25.50 |
| Average True Range (ATR) | 0.15 | 2.71 |
| MACD | -0.02 | 0.13 |
| Stochastic Oscillator | 35.77 | 47.37 |
Price Performance
Historical ComparisonAbout SANG Sangoma Technologies Corporation
Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.